title: [Study on primary hepatocellular carcinoma associated with hypersplenism treated by partial splenic embolization combined with hepatic arterial chemoembolization].
abstract: OBJECTIVE
  70-90% of patients of primary hepatocellular carcinoma (PHC) are associated with liver cirrhosis, portal hypertension and hypersplenism. The treatment of PHC is usually hampered by low or slow recovery of blood cell counts. This study was to investigate the effect of partial splenic embolization (PSE) combined with transcatheter hepatic arterial chemoembolization (TACE) for the treatment of PHC with portal hypertension and hypersplenism.
  
  
  METHODS
  Efficacy of 26 patients with PSE combined with TACE and 26 patients with single TACE was observed.
  
  
  RESULTS
  Satisfactory effects were achieved in PSE combined with TACE group in terms of correction of blood cell counts compared with cases treated with TACE alone.
  
  
  CONCLUSIONS
  PSE associated with TACE is safe and effective for the treatment of patients with PHC associated with liver cirrhosis, portal hypertension and hypersplenism.
authors.affiliation: Department of Imaging and Interventional Radiology, Cancer Center, Sun Yat-sen University, Guangzhou, Guangdong, 510060, P. R. China. huangjhmd@yahoo.com
authors.forename: Jin-Hua
authors.initials: JH
authors.lastname: Huang
authors.forename: Pei-Hong
authors.initials: PH
authors.lastname: Wu
authors.forename: Yang-Kui
authors.initials: YK
authors.lastname: Gu
authors.forename: Fu-Jun
authors.initials: FJ
authors.lastname: Zhang
authors.forename: Chuan-Xing
authors.initials: CX
authors.lastname: Li
authors.forename: Fei
authors.initials: F
authors.lastname: Gao
authors.forename: Liang
authors.initials: L
authors.lastname: Zhang
authors.forename: Wei-Jun
authors.initials: WJ
authors.lastname: Fan
authors.forename: Chang-Jiang
authors.initials: CJ
authors.lastname: Li
mesh_terms: D000328:Adult; D001772:Blood Cell Count; D006528:Carcinoma, Hepatocellular / Q000097:blood / Q000098:blood supply / Q000150:complications / Q000628:therapy*; D016461:Chemoembolization, Therapeutic; D004621:Embolization, Therapeutic / Q000379:methods; D005260:Female; D006499:Hepatic Artery; D006801:Humans; D006971:Hypersplenism / Q000097:blood / Q000150:complications / Q000628:therapy*; D007459:Iodized Oil; D008113:Liver Neoplasms / Q000097:blood / Q000098:blood supply / Q000150:complications / Q000628:therapy*; D008297:Male; D013157:Splenic Artery
chemical_list: D007459:Iodized Oil